MetaCap

CervoMed (CRVO) vs Rockwell Medical (RMTI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Rockwell Medical (RMTI) has outperformed CervoMed (CRVO) over the past year, losing 34.6% versus a loss of 83.6%. Over five years, RMTI leads with a -88.0% price change compared with -95.0% for CRVO. Rockwell Medical is the larger company by market cap ($23.1 million vs $22.1 million), about 1.0 times the size.

Rockwell Medical converts more of its revenue into profit, with a net margin of -7.7% versus -673.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CRVO-83.56%RMTI-34.61%
+48%-22%-91%
Nov 21, 20251 yearNov 20, 2026
CRVO-95.01%RMTI-88.98%
+8%-46%-100%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CRVO versus RMTI key metrics
MetricCRVORMTI
Share price$1.46$5.82
Market cap$22.09M$23.12M
1-day change+9.77%-7.03%
YTD return-81.52%-29.88%
1-year return-83.56%-34.61%
5-year return-95.01%-87.98%
Forward P/E—83.14
EPS (TTM)$-2.65$-1.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$4.01M$69.26M
Revenue growth (YoY)-58.86%-31.76%
Net income (latest FY)$-26.97M$-5.31M
Gross margin—16.89%
Operating margin-706.22%-6.77%
Net margin-673.06%-7.67%
52-week high$10.00$12.90
52-week low$1.27$4.89
Distance from 52-week high-85.40%-54.88%
Analyst consensusstrong_buynone
Avg. price target upside+954.79%+243.64%
Average volume489.10K25.91K
Shares outstanding15.13M3.97M
Employees15157
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RMTI has outperformed CRVO by 49.0 percentage points over the past year.
  • Rockwell Medical is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -673.1 cents for CervoMed.
  • Rockwell Medical grew revenue faster in its latest fiscal year (-31.76% vs -58.86%).

About CervoMed

CRVO stock →

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a.

Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees

About Rockwell Medical

RMTI stock →

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.

Health Care · Biotechnology: Pharmaceutical Preparations · 157 employees

CRVO vs RMTI FAQ

Which is bigger, CervoMed or Rockwell Medical?

Rockwell Medical (RMTI) is larger, with a market capitalization of $23.12M compared with $22.09M for CervoMed (CRVO).

Which stock has performed better over the past year, CRVO or RMTI?

RMTI returned -34.61% over the past 12 months, compared with -83.56% for CRVO (price return, excluding dividends). Past performance does not predict future results.

Are CervoMed and Rockwell Medical in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons